Thomas Reilly
Director of Finance/CFO en AMARIN CORPORATION PLC .
Fortuna: 191 890 $ al 31/03/2024
Perfil
Thomas Reilly is currently the CFO, Executive VP, Head-Global HR & Finance at Amarin Corp.
Plc.
Previously, he worked as the Head-Finance Medicines Business at Allergan, Inc. and as the Chief Financial & Accounting Officer at CARA Therapeutics, Inc. He completed his undergraduate degree at Manhattan College and holds an MBA from Seton Hall University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AMARIN CORPORATION
0.06% | 20/02/2024 | 215 365 ( 0.06% ) | 191 890 $ | 31/03/2024 |
Cargos activos de Thomas Reilly
| Empresas | Cargo | Inicio |
|---|---|---|
| AMARIN CORPORATION PLC | Director of Finance/CFO | 20/06/2022 |
Antiguos cargos conocidos de Thomas Reilly.
| Empresas | Cargo | Fin |
|---|---|---|
| CARA THERAPEUTICS, INC. | Director of Finance/CFO | 15/06/2022 |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
Formación de Thomas Reilly.
| Manhattan College | Undergraduate Degree |
| Seton Hall University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| CARA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Reilly
